<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn></journal-meta><article-meta><article-id pub-id-type="pmid">7734295</article-id><article-id pub-id-type="pmc">2033766</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hietanen</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Blomqvist</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wasenius</surname><given-names>V. M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Niskanen</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Franssila</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nordling</surname><given-names>S.</given-names></name></contrib></contrib-group><aff>Department of Radiotherapy and Oncology, University Central Hospital of Helsinki, Finland.</aff><pub-date pub-type="ppub"><month>5</month><year>1995</year></pub-date><volume>71</volume><issue>5</issue><fpage>1029</fpage><lpage>1032</lpage><abstract><p>The relationship between the response to chemotherapy with cyclophosphamide, epirubicin and fluorouracil as well as the time to progression of metastasised breast cancer and DNA ploidy and S-phase fraction (SPF) of primary tumours was examined using paraffin-embedded tumour tissue from 81 patients. The response to chemotherapy was significantly better in patients with tumours with a high SPF, and in addition the time to progression was longer in the high-SPF group. There was no significant difference when the DNA ploidy and response to treatment were compared.</p></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00051-0133.tif" xlink:title="scanned-page" xlink:role="1029" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00051-0134.tif" xlink:title="scanned-page" xlink:role="1030" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00051-0135.tif" xlink:title="scanned-page" xlink:role="1031" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00051-0136.tif" xlink:title="scanned-page" xlink:role="1032" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

